Drug Trial Radar · NCT05703919
Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease
Last checked: Nov 19, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,888
Planned (sponsor's estimate)
Start
Jun 2, 2025
Primary completion
Feb 29, 2028
Study completion May 31, 2028
Sponsor
- Lead sponsor
- Central Denmark RegionAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 30, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The STOP-COPD trial is a randomized, patient-blinded, prehospital clinical trial designed to evaluate the effect of titrated oxygen therapy compared to standard oxygen treatment in patients with suspected acute exacerbation of chronic obstructive pulmonary disease (AECOPD) treated with inhaled bronchodilators. The primary objective is to determine whether a titrated oxygen strategy targeting SpO₂ 88-92% can reduce 30-day mortality compared to the current standard practice using 100% compressed oxygen as a nebulizer driver.
Conditions
- COPD Exacerbation
- COPD Exacerbation Acute
Interventions
Titrated OxygenDrug
Titrated oxygen strategy - a mix of supplemental oxygen and compressed atmospheric air as driver for inhaled bronchodilators to target SpO2 88-92%
Standard OxygenDrug
Standard care using compressed oxygen (100%) as driver for inhaled bronchodilators
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mortality, 30-dayTime frame: Day 30 from randomization
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Prehospital Emergency Medical Servises, Central Denmark Region
Aarhus N, Denmark · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.